Mandate

Vinge advises Ambea on its acquisition of Aleris Care

October 16, 2018 Banking and Finance

Vinge has advised Ambea on its acquisition of Aleris’ care operations (“Aleris Care”) from Sirela Sweden AB, which is indirectly owned by Investor through Patricia Industries.

The purchase price amounted to SEK 2.6 billion on a debt free case free basis. Aleris Care is the leader in the private market for care services in Norway, the sixth largest private operator in Sweden and the largest private provider in the Denmark. Today, Ambea is the second largest player in the private market for care services in Sweden and the seventh largest in Norway. Following the acquisition, Ambea will be the largest care provider in the Nordic region with operations in Sweden, Norway and Denmark. The transaction is subject to regulatory approval by the relevant competition authorities and closing is expected to occur during the first quarter of 2019.
 
Vinge’s team consisted of partners Christina Kokko (M&A), Charlotte Levin (Public M&A and Capital Markets), Albert Wållgren (Banking and Finance) and Johan Karlsson (Competition) together with associates Johanna Wiberg, Martin Cronsioe and Karolina Cohrs (M&A), Linn Adelwald, Josefine Lanker and Josefine Larsson (Banking and Finance), Nicklas Thorgerzon, Fredrika Hjelmberg, Hayaat Ibrahim and Victor Berg (Commercial Agreements), Klara Secher (IP), Kristoffer Larson (Real Estate), Sara Strandberg and Lisa Ullman (Employment), Trine Osen Bergqvist, Xandra Ståhlberg and Sofia Landolsi (Competition), Hannes Pettersson (Corporate), Maria Schultzberg, Victor Ericsson and Henrik Wastenson (Tax) and VDR assistant Jessica Öijer. 

Selmer (Norway) and Accura (Denmark) has advised on the transaction’s Norwegian and Danish legal and tax aspects. 
 

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025